Overview
Invokana, Farxiga, and other related type 2 diabetes drugs have been linked to a serious condition known as ketoacidosis.
Diabetes Drug Update – Invokana and Farxiga
In May 2015, the FDA issued a Safety Communication advising that certain Type 2 Diabetes drugs may result in a serious condition known as ketoacidosis.
Holly Dolejsi of Robins Kaplan LLP Appointed Co-Lead Counsel in Farxiga Multidistrict Litigation
Judge Lorna G. Schofield has appointed Robins Kaplan attorney Holly Dolejsi as co-lead counsel in multidistrict litigation (MDL) involving the diabetes drug Farxiga.
Robins Kaplan LLP Investigates Type 2 Diabetes Drugs and Severe Injuries, Including Ketoacidosis
Invokana and other related type 2 diabetes drugs have been linked to a serious condition known as ketoacidosis.
Robins Kaplan LLP Attorney Holly Dolejsi Appointed to Plaintiffs’ Steering Committee for the Invokana Multidistrict
Judge Brian R. Martinotti of the District of New Jersey entered an order on Jan. 24 appointing Holly Dolejsi to the Plaintiffs’ Steering Committee for the Invokana multidistrict litigation.
